Holen Sie sich die Stockscreener-App
43.45
1.96%
-0.87
Handel nachbörslich:
43.31
-0.14
-0.32%
Schlusskurs vom Vortag:
$44.32
Offen:
$44.14
24-Stunden-Volumen:
1.62M
Relative Volume:
0.51
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.95%
1M Leistung:
+5.85%
6M Leistung:
+53.21%
1J Leistung:
+73.25%
1-Tages-Spanne:
$43.08
$44.30
1-Wochen-Bereich:
$42.77
$45.13
52-Wochen-Spanne:
$23.43
$45.13
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Firmenname
ARK Genomic Revolution ETF
Sektor
Branche
Telefon
855-406-1506
Adresse
-
Compare ARKG vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
43.45 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
383.85 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
776.34 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
780.04 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
309.29 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
731.07 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF Aktie (ARKG) Neueste Nachrichten
ARK Investment Management (MASS) reports 2.0M-share, 5.32% holding in 908 Devices - Stock Titan
Cathie Wood Pivots $25 Million Into Cerebras While Dumping Palantir After 93% Revenue Surge - finance.biggo.com
Behavioral Patterns of ARKG and Institutional Flows - Stock Traders Daily
🧬 DNA Stock | Is Ginkgo Bioworks The Next Amazon Stock? Eswatini (usFV0zKJfR) - Mshale
5 Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
ETF Talk: The Biotech Revolution Will Not Be Televised… - stockinvestor.com
Cathie Wood Scoops Up $26.6 Million in Nvidia Shares Across Five ARK ETFs Amid AI Infrastructure Push - finance.biggo.com
Cathie Wood loads up SpaceX, AI infra names, continues trimming Roblox, Palantir (ARKK:BATS) - Seeking Alpha
ARKC ETF Profile: Dividends, Returns (LSE:ARKC) - TradingView
Cathie Wood's ARK Invest Pours $22 Million Into Block After Post-Earnings Selloff, Cuts Shopify and Palantir - finance.biggo.com
Cathie Wood’s ARK buys SpaceX, Nvidia; offloads Roblox, Palantir (RBLX:NYSE) - Seeking Alpha
AAKG ETF Profile: Dividends, Returns (XETR:AAKG) - TradingView
Trending Industry Today: ARK Autonomous Technology & Robotics ETF Leads Gains In ARK ETFs Stocks - Moomoo
(ARKG) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
ARK Genomic Revolution ETF (ARKG) Options Chain - Yahoo! Finance Canada
ARKK: Underwhelming Results To Continue In 2026 (BATS:ARKK) - Seeking Alpha
Cathie Wood’s ARK buys $15.6M in Nvidia shares across five ETFs - eciks.org
Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy? - AOL.com
ARK Genomic Revolution ETF rebounds after 15% d... - Pluang
Caris Life Sciences Inc (CAI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
A14Y8G ETF Profile: Dividends, Returns (LS:A14Y8G) - TradingView
Pacific Biosciences of California Inc (PACB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Butterfly Network Inc (BFLY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
10X Genomics Inc (TXG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Absci Corp (ABSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Schrodinger Inc (SDGR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Intellia Therapeutics Inc (NTLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
908 Devices Inc. (MASS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beam Therapeutics Inc (BEAM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
How is ARKG Performing in the Current Market Environment - Kavout | AI
Prime Medicine Inc (PRME) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arcturus Therapeutics Holdings Inc (ARCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
0CQL ETF Profile: Dividends, Returns (LSE:0CQL) - TradingView
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tempus AI Inc (TEM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Twist Bioscience Corp (TWST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cathie Wood’s ARK sells Figma stock, buys Scribe Therapeutics By Investing.com - Investing.com Nigeria
BioNTech’s Pumitamig Hopes Face a Reality Check as ARK Exits and the Stock Hovers at a Technical C - Ad-hoc-news.de
1ARG ETF Profile: Dividends, Returns (LSE:1ARG) - TradingView
A408AY ETF Profile: Dividends, Returns (LS:A408AY) - TradingView
Cathie Wood Sells HOOD, Buys More SPCX: What ARK's Latest Moves SignalARK Innovation ETF (BATS:ARKK) - Benzinga
Cathie Wood’s ARK Sells HOOD Stock Again – Even As Robinhood Hits 1M Gold Cards, Launches Platinum Card - TradingView
Cathie Wood Swaps Robinhood for SpaceX, Archer—Did ARK Pivot Back to Moonshot Innovation? - Sahm
More NTLA, Less RKLB: Cathie Wood’s Latest ARK Trades Explained - Stocktwits
How (ARKG) Movements Inform Risk Allocation Models - Stock Traders Daily
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating - The Motley Fool
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating - The Motley Fool
Cathie Wood's Ark Invest sold $7.4 million of BioNTech stock - MSN
Cathie Wood buys $2 million of tumbling AI stock - MSN
ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026. - Pluang
ETF Showdown: ARKG vs GNOM, Which Genomics Fund Wins? - Yahoo Finance
Finanzdaten der ARK Genomic Revolution ETF-Aktie (ARKG)
Es liegen keine Finanzdaten für ARK Genomic Revolution ETF (ARKG) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.43%
0.32%
Kapitalisierung:
|
Volumen (24h):